Physician profile
Stephen Lewis Patrick
NPI 1942825187
$3,463.72
in general payments reported to CMS, 2019-2025
18 companies · $1,333 in 2025
The $1,333 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $88.58 · 2021: $178 · 2022: $318 · 2023: $1,196 · 2024: $350 · 2025: $1,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,546 · Travel and Lodging: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,546.14 |
| Travel and Lodging | $333.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,462.31 | 2020-2025 | Ams 700, Advance Xp, Greenlight Xps |
| Medtronic, INC. | $741.92 | 2022-2025 | Altaviva, Interstim |
| Procept Biorobotics Corporation | $355.66 | 2023-2025 | Aquabeam Robotic System |
| Coloplast Corp | $209.49 | 2022-2025 | Speedicath |
| Urogen Pharma, INC. | $154.93 | 2023-2024 | Jelmyto |
| Endo Pharmaceuticals INC. | $137.55 | 2023 | Xiaflex |
| Axonics, INC. | $88.57 | 2022-2023 | Axonics |
| Sumitomo Pharma America, INC. | $48.75 | 2024-2025 | Gemtesa |
| Teleflex LLC | $41.84 | 2022-2023 | Urolift |
| Endo USA, INC. | $36.21 | 2025 | Xiaflex, Aveed |
| Convatec INC. | $28.61 | 2025 | |
| Blue Earth Diagnostics | $28.04 | 2025 | Posluma |
| Merck Sharp & Dohme LLC | $23.75 | 2025 | Keytruda, Keytruda Qlex |
| Profound Medical Corp. | $23.56 | 2025 | Tulsa-Pro |
| Ferring Pharmaceuticals INC. | $23.11 | 2025 | Adstiladrin |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $22.61 | 2025 | |
| Laborie Medical Technologies Corp. | $21.92 | 2025 | |
| 180 Medical, INC. | $14.89 | 2025 | Gentlecath Glide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.